Tuberculosis
Findings from the United States and Canada advance knowledge in tuberculosis research
Published in TB and Outbreaks Week, August 1st, 2006
Study 1: The QuantiFERON-TB assay and skin testing identifies latent tuberculous infection.
"Individual's infected with nontuberculous mycobacteria may elicit false-positive reactions on tuberculin skin testing. The QuantiFERON-TB (QFT) assay utilizes tuberculin and M. avium antigens and, therefore, may be more specific for latent tuberculosis infection," researchers in the United States report.
According to the authors, "The objective of this study was to investigate the agreement between the QFT and single and dual antigen skin testing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Antituberculosis Drug Development
Antitubercular drugs encapsulated in alginate nanoparticles have increased bioavailability - Tuberculosis Control
Multidrug-resistant tuberculosis control program in New York City improves outcome - Tuberculosis Outbreaks
Tuberculosis outbreak involved multiple transmission sites in homeless population - Tuberculosis Risk Factors
Risk factors identified for drug-resistant tuberculosis in British Columbia - AIDS/Tuberculosis Coinfection
Schistosoma mansoni is associated with progression to active tuberculosis in HIV/AIDS - Abdominal Tuberculosis
Abdominal tuberculosis diagnosed by PCR - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
